< Back to previous page
Organisation
HIV/STI Clinic
Current researchers
1 - 10 of 20 results
- Maureen Aerts (Member)
- Ludwig Apers (Member)
- Vincent Barvaux (Member)
- Séverine Caluwaerts (Member)
- Emmanuelle Cleve (Member)
- Eva Hemelaer (Member)
- Corinne Herrijgers (Member)
- Veerle Huyst (Member)
- Ilse Kint (Member)
- Cora Lamonte (Member)
Projects
1 - 9 of 9
- Contemporary challenges in Human Immunodeficiency Virus Pre-Exposure-Prophylaxis care in BelgiumFrom15 Nov 2022 → Today
- PReventing the Emergence of untreatable STIs via radical PreventionFrom1 Jan 2021 → Today
- Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuningFrom19 Nov 2020 → 31 Dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportFrom20 Oct 2020 → 20 Oct 2021
- Optimise PrEP to Maximise ImpactFrom1 Jan 2019 → 31 Dec 2023
- Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised careFrom1 May 2015 → 30 Sep 2020
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureFrom1 Nov 2014 → 31 Oct 2018
- Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possibleFrom1 Jul 2014 → 31 Dec 2019
- Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeFrom1 Apr 2014 → 30 Sep 2017
Publications
1 - 10 of 296
- How to improve HIV prevention? Development, implementation and evaluation of combination prevention interventions among key populations.(2018)
Authors: Tom Platteau
Number of pages: 146 - Diagnose en therapie van SOA(1998)
Authors: Marc Vandenbruaene, T Van Haegenborgh
Pages: 1-15 - Korte kuren met AZT(1998)
Authors: Marc Vandenbruaene
Pages: 1-2 - Epidemiologie van seksueel overdraagbare aandoeningen(1993)
Authors: Marc Vandenbruaene
Pages: 1503-1505 - Feasibility, uptake and acceptability of the EmERGE mHealth app in individuals living with stable HIV in five European countries(2019)
Authors: J. Whetham, C. Jones, S. Bremner, D Aguilar Leon, J Begovac, L Apers, M. Borges, S. Zekan, E. Teofilo, F Garcia
Pages: 209-209 - The changing spectrum of the cutaneous manifestation of HIV disease [letter](1999)
Authors: R Colebunders, Marc Vandenbruaene
Pages: 471 - Management of kaposi's sarcoma in resource-limited settings in the era of HAART(2005)
Authors: L Lynen, M Zolfo, V Huyst, P Barnardt, A Van de Velde, CAROLINE DE SCHACHT, R Colebunders
Pages: 13-21 - Reasons for HIV diagnosis delay in Antwerp [letter](1994)
Authors: Lutgart Van Damme, R Colebunders, F Khamassi, Y Fleerackers, H Van Renterghem, J Goeman, M Vandenbruaene
Pages: 366-368 - Rheumatological complications associated with the use of indinavir and other protease inhibitors(2002)
Authors: E Florence, W Schrooten, K Verdonck, CHRISTA DREEZEN, R Colebunders
Pages: 82-84 - Treatment of multidrug-resistant tuberculosis [letter](2004)
Authors: R Colebunders, LM Apers, IC Shamputa
Pages: 1240